Antagonism of interleukin-18 binding protein (IL-18BP) with a “decoy-to-the-decoy” IL-18 construct that did not signal, but rather bound IL-18BP, resulted in enhanced innate lymphoid cell and T cell responses and improved parasite control.
[Cell Reports]